Article Text

PDF

Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study
  1. Jawad Fares1,2,
  2. Anwar H Nassar3,
  3. Souheil Gebeily1,4,
  4. Firas Kobeissy5,6,
  5. Youssef Fares1,7
  1. 1Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
  2. 2Faculty of Medicine, American University of Beirut, Beirut, Lebanon
  3. 3Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon
  4. 4Department of Neurology, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
  5. 5Department of Psychiatry, College of Medicine & McKnight Brain Institute, University of Florida, Gainesville, Florida, USA
  6. 6Department of Biochemistry and Molecular Genetics, American University of Beirut Medical Center, Beirut, Lebanon
  7. 7Department of Neurosurgery, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
  1. Correspondence to Professor Youssef Fares; yfares{at}ul.edu.lb

Abstract

Objective The Lebanese Multiple Sclerosis (LeMS) study aims to assess the influence of pregnancy and delivery on the clinical course of multiple sclerosis (MS) in Lebanese women.

Setting This prospective multicentre study took place in three MS referral university medical centres in Lebanon.

Participants Included were 29 women over 18 years who had been diagnosed with MS according to the McDonald criteria, and became pregnant between 1995 and 2015. Participating women should have stopped treatment 3 months before conception and become pregnant after the onset of MS. Women were followed up from 1 year preconceptionally and for 4 years postpartum.

Main outcome measures The annualised relapse rates per participant during each 3-month period during pregnancy and each year postpartum were compared with the relapse rate during the year before pregnancy using the paired two-tailed t test. p Values <0.05 were considered statistically significant for all analyses (95% CI).

Results 64 full-term pregnancies were recorded. All pregnancies (100%) resulted in live births, with no complications or other diseases. In comparison with the prepregnancy year, in which the mean relapse rate±SE was 0.17±0.07, there was a significant reduction in the relapse rate during pregnancy and in the first year postpartum (p=0.02), but an increase in the rate in the second year postpartum (0.21±0.08). Thereafter, from the third year postpartum through the following fourth year, the annualised relapse rate fell slightly but did not differ from the annualised relapse rate recorded in the prepregnancy year (0.17±0.07).

Conclusions Pregnancy in Lebanese women with MS does not seem to increase the risk of complications. No relapses were observed during pregnancy and in the first year postpartum; however, relapses rebounded in the second year postpartum, and over the long term, returned to the levels that preceded pregnancy.

  • Pregnancy
  • Relapse
  • Management
  • Outcomes
  • Interferon beta

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.